<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01250626</url>
  </required_header>
  <id_info>
    <org_study_id>DMR99-IRB-139</org_study_id>
    <nct_id>NCT01250626</nct_id>
  </id_info>
  <brief_title>Establish the Caring Model of Children With Chronic Kidney Disease and End-stage Renal Disease: To Set up Childhood Glomerular Filtration Rate (GFR) Formula in Taiwan</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>China Medical University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China Medical University Hospital</source>
  <brief_summary>
    <textblock>
      Inulin's usefulness as a diagnostic agent is based on the method of its elimination from the
      body. Inulin is biologically inert, unbound by plasma proteins, freely filtered at the
      glomerulus, and is neither reabsorbed, metabolized nor secreted by the kidneys. It is
      excreted almost entirely by glomerular filtration. Inulin clearance is considered to be
      identical to glomerular filtration rate (GFR).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>August 2010</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">80</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <condition>End-Stage Renal Disease</condition>
  <arm_group>
    <arm_group_label>a single-group study</arm_group_label>
    <description>Pediatric OPD, age &lt; 18 y/o.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Pediatric OPD, age &lt; 18 y/o.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        1. Main inclusion criteria: Pediatric OPD, age &lt; 18 y/o.

          2. Main exclusion criteria: Acute renal failure, edema, muscular dystrophy, pleural
             effusion, ascites, malnutrition, neurogenic bladder, heart failure and ketoacidosis.
             And taken cimetidine or trimethoprim, and accepted renal replacement therapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 29, 2010</study_first_submitted>
  <study_first_submitted_qc>November 30, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2010</study_first_posted>
  <last_update_submitted>November 30, 2010</last_update_submitted>
  <last_update_submitted_qc>November 30, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 1, 2010</last_update_posted>
  <responsible_party>
    <name_title>Ching-Yuang Lin, M.D.,PhD.</name_title>
    <organization>China Medical University</organization>
  </responsible_party>
  <keyword>Inulin</keyword>
  <keyword>childhood GFR formula</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

